Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03949023 · ClinicalTrials.gov registry record
Influence of Contrast Injection Force on the Accuracy of Vessel Measurements in Cerebral Angiography
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- 1
- Enrollment target
NCT03949023 is a clinical trial that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 1 participants.
The verdict
NCT03949023 was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
The purpose of this research study is to collect data/measurements that are routinely collected in standard of care cerebral angiogram
Interventions
- PROCEDURE Standard of Care Cerebral Angiogram Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-07-12 |
| Est. Completion | 2018-07-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03949023
The ClinicalTrials.gov registry entry for NCT03949023 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Standard of Care Cerebral Angiogram Group is the first listed.
NCT03949023 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03949023 about?
NCT03949023 is a clinical study titled "Influence of Contrast Injection Force on the Accuracy of Vessel Measurements in Cerebral Angiography". The purpose of this research study is to collect data/measurements that are routinely collected in standard of care cerebral angiogram
What is the current status of trial NCT03949023?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2018-07-12. Estimated completion is 2018-07-12.
What interventions are being tested in trial NCT03949023?
The interventions under investigation include: Standard of Care Cerebral Angiogram Group (PROCEDURE).
Who is sponsoring clinical trial NCT03949023?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.